QR-kod

Protocol for a multicentric open-label randomized controlled trial comparing low-dose (0.25 mg/kg) and standard-dose (0.75 mg/kg) primaquine for gametocytocidal efficacy and safety in Plasmodium falciparum malaria

Abstract Introduction World Health Organization (WHO) in 2010, recommended 0.75 mg/kg single dose primaquine for killing gametocytes after ruling out glucose-6-phosphate dehydrogenase (G6PD) deficiency. However, considering the practical feasibility of G6PD testing, WHO revised the recommendation in...

Full beskrivning

Sparad:
Huvudupphov: Payal Gulati, Richa Singhal, Apoorv Gupta, Anjali, Praveen Kumar Tripathi, Dewesh Kumar, Diamond Prakash Sinha, S. P. Singh, Khileshwar Singh, Rajendra Kumar Baharia, K. N. Bhatt, Ashvin H. Vasava, Amit Gamit, Manoj B. Patki, Waseem A. Malla, Lokesh Kori, Deepali Savargaonkar, Nibir Chakma, Daksh Parmar, Lenin Alagesan, Ritika Kashyap, Kuldeep Singh, Anup R. Anvikar, Praveen K. Bharti, Nitika Nitika
Materialtyp: Artigo
Språk:Inglês
Utgiven: BMC 2026-05-01
Serie:Malaria Journal
Ämnen:
Primaquine
Gametocyte clearance
Plasmodium falciparum
Efficacy
Safety
India
Länkar:https://doi.org/10.1186/s12936-026-05912-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk